Issues
Current Issue
Special Issues
Viewpoints
Editor’s Corner
Advanced Practice Voices
From Our Readers
You Make the Call: Readers’ Response
Guest Commentary
Letters to the Editor
A Day in the Life
Notes From the Hill
The Break Room
Education
You Make the Call
Hematologica Obscura
How I Teach
How I Treat In Brief
Demystifying the Lab
Practice Update
Spotlight
Feature Articles
Pulling Back the Curtain
Blood Beyond Borders
pASHions
Drawing First Blood
HemOnc Link
Interviews
News
Online Exclusives
Latest & Greatest
From the
Blood
Journals
Written in
Blood
Blood Advances
in a Different Vein
Literature Scan
ASH Directions
The Society Pages
Topic Compilations
COVID-19 News
Acute Leukemias
Chronic Leukemias
MDS & Myeloproliferative Neoplasms
Multiple Myeloma & Plasma Cell Disorders
Lymphomas & Lymphoid Neoplasia
Bleeding Disorders
Clotting Disorders
Red Blood Cell & Iron Disorders
On Location
ASH Annual Meeting
ASH Meeting on Hematologic Malignancies
ASH Meeting on Lymphoma Biology
Other Meetings
Multimedia
Sound Bites
Meeting Coverage
Search
ASH Home
About ASH Clinical News
Authors
Advertising
Subscribe
Contact Us
eNewsletters
Cookie Settings
LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
Issues
All
Current Issue
Special Issues
October 2021, Volume 7, Issue 12
September 2021 Volume 7 Issue 11
August 2021 Volume 7 Issue 10
July 2021 Bonus Mid-Year Edition, Volume 7 Issue 9
Viewpoints
Editor’s Corner
Advanced Practice Voices
From Our Readers
You Make the Call: Readers’ Response
Guest Commentary
Letters to the Editor
A Day in the Life
Notes From the Hill
The Break Room
Education
You Make the Call
Hematologica Obscura
How I Teach
How I Treat In Brief
Demystifying the Lab
Practice Update
Spotlight
Feature Articles
Pulling Back the Curtain
Blood Beyond Borders
pASHions
Drawing First Blood
HemOnc Link
Interviews
News
Online Exclusives
Latest & Greatest
From the
Blood
Journals
Written in
Blood
Blood Advances
in a Different Vein
Literature Scan
ASH Directions
The Society Pages
Topic Compilations
COVID-19 News
Acute Leukemias
Chronic Leukemias
MDS & Myeloproliferative Neoplasms
Multiple Myeloma & Plasma Cell Disorders
Lymphomas & Lymphoid Neoplasia
Bleeding Disorders
Clotting Disorders
Red Blood Cell & Iron Disorders
On Location
ASH Annual Meeting
ASH Meeting on Hematologic Malignancies
ASH Meeting on Lymphoma Biology
Other Meetings
Multimedia
Sound Bites
Meeting Coverage
Generic selectors
Exact matches only
Exact matches only
Search in title
Search in title
Search in content
Search in content
Search in excerpt
Search in posts
Search in posts
Search in pages
Search in pages
Home
Authors
Posts by ajones
ajones
328 POSTS
0 COMMENTS
Isatuximab Combination Improves Progression-Free Survival in Pretreated Myeloma
Sunday, September 1, 2019
AMG 420 Continues to Show Efficacy in Relapsed/Refractory Myeloma
Monday, July 15, 2019
Can Women With CML Safely Continue TKIs During Pregnancy?
Saturday, June 15, 2019
Nivolumab Associated With High Response Rates in Relapsed/Refractory PMBL
Saturday, June 15, 2019
Single-Agent Acalabrutinib Improves Survival in Relapsed/Refractory Chronic Lymphocytic Leukemia
Saturday, June 15, 2019
Robert Kreitman: Delayed Versus Concurrent Rituximab in Hairy Cell Leukemia
Monday, June 10, 2019
Tibor Kovacsovics: CX-01 Associated With High Response Rates in Older Patients...
Monday, June 10, 2019
Paul Richardson: Isatuximab Improves PFS in Relapsed/Refractory Myeloma
Monday, June 3, 2019
Iman Abou Dalle: Leuprolide Improves Post-Chemotherapy Recovery in Patients With Leukemia
Monday, June 3, 2019
New Subcutaneous Daratumumab Formulation Overcomes Infusion Barrier for Patients
Monday, June 3, 2019
1
2
3
...
33
Page 1 of 33
Advertisement
Current Issue
October 2021, Volume 7, Issue 12
Friday, October 1, 2021
This issue tells the long story of drug shortages, demystifies transfusion services, and more.
Block title
Ruxolitinib Approved for Chronic Graft-Versus-Host Disease
Wednesday, October 20, 2021
Crizanlizumab Approved for Sickle Cell Disease in the U.K.
Wednesday, October 20, 2021
FDA Halts Allogene Cell Therapy Trials
Wednesday, October 20, 2021
Pilot Study Finds Remote Monitoring of Patients Undergoing Chemotherapy Feasible
Tuesday, October 19, 2021
Could AP-Led Quality and Safety Grand Rounds Improve Patient Outcomes?
Tuesday, October 19, 2021
